Aljazeera Hospital
66
3
3
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 66 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (66)
Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography
Role: collaborator
Verbal Analgesia Versus Standard Care for Pain Control in Women With Primary Infertility Undergoing Office Hysteroscopy
Role: collaborator
The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis
Role: lead
Ovarian Hyperstimulation Syndrome Prevention
Role: lead
Atrificial Shrinkage of Blastocyst Before In Vitro Fertilization
Role: lead
Endometrial Assessment of Women With Uterine Infection
Role: lead
Misoprostol Versus Active Management of Labour in CS
Role: lead
Effect of Subcutaneous Tissue Closure on Wound Complications
Role: lead
Recombinant Factor VII for Intractable Postpartum Haemorrhage
Role: lead
Modified Cervical Inversion During CS in Placenta Previa
Role: lead
Evaluation of TP US in Women With Prolapse
Role: lead
Bisphenol Role in the Pathogenesis of PCOS
Role: lead
Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy
Role: lead
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
Role: lead
Physical Endometrial Manipulation and Its Effect on ICSI
Role: lead
3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas
Role: lead
Tab Block and Patient Controlled Analgesia in CS
Role: lead
Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCO
Role: lead
Hysterosalpingography and Hysteroscopy in ICSI
Role: lead
Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin
Role: lead